Interactions with multiple peptide ligands determine the fate of developing thymocytes

Area of Science:

• Immunology
• T cell biology
• Developmental immunology

Background:

• T cell selection in the thymus is crucial for immune system function.
• Interactions between T cell receptors (TCR) and peptide-MHC complexes dictate thymocyte fate.
• Antigenic peptides induce apoptosis (negative selection) or survival (positive selection) of thymocytes.

Purpose of the Study:

• To investigate the effect of an antagonist peptide on natural negative selection in thymocytes.
• To determine if antagonist peptides can rescue thymocytes from deletion in a physiological model.
• To characterize the functional capacity of T cells rescued by antagonist peptide treatment.

Main Methods:

• Utilized fetal thymic organ cultures (FTOC) from alpha beta TCR-transgenic mice (F5).
• Administered an antagonist peptide to inhibit natural negative selection induced by endogenous antigen.
• Assessed thymocyte survival, maturation, and T cell function (cytokine production, cytolytic activity).

Main Results:

• The antagonist peptide successfully inhibited natural negative selection in FTOC, rescuing otherwise deleted thymocytes.
• Mature T cells generated showed reduced interferon-gamma production and required exogenous IL-2 for cytolytic effector cell development.
• The antagonist peptide accelerated thymocyte development even without a negatively selecting ligand.

Conclusions:

• Thymocyte developmental fate is influenced by recognition of multiple peptide ligands during thymic selection.
• Modulating peptide presentation in the thymus can significantly alter the size and autoreactive potential of the T cell repertoire.
• Antagonist peptides offer a potential tool to manipulate T cell development and repertoire generation.